Pfizer Inc. is trading 2.6% down today at $9505.00 following the announcement that its Chief Financial Officer, Dave Denton, will step down from his role effective August 15, 2026.
- The company has named Cecile Guegan, Senior Vice President of Finance, Global Biopharmaceutical Business, as the Interim Chief Financial Officer, effective August 16, 2026, while a comprehensive search for a permanent successor is conducted.
- Denton is leaving for a professional opportunity outside the pharmaceutical industry in consumer goods, and his departure is not related to the company's financial or operating results.